Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency

Name: Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency
License: Public Domain

Novartis

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

diabetes mellitus, type 2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 471582
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.